KRMD
KORU MedicalANasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-23
Current thesis
Q1 showed strong revenue growth, international momentum, core-market share gains, and improving loss metrics. Continued prefilled-syringe conversions and clinical-trial adoption could support the reiterated outlook and longer-term platform expansion.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
510(k) and Phase III collaboration outcomes have uncertain timing and commercial conversion.
Momentum
96
Value
42
Sentiment
62
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.10 · Bull $6.80 · Bear $2.90
Data freshness
Prices
As of 2026-07-23
Fundamentals
As of 2026-07-23 • Vendor: Data Vendor v1
Scores
As of 2026-07-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-23 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-23
Investment thesis
As of 2026-07-23
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $6.80
Why
Momentum96 · Δ7d -
Value42 · Δ7d -0.0
Sentiment62 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
96
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
42
39% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
62
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 96.0 / Value 41.7 / Sentiment 62.0
Fundamentals (TTM)As of 2026-07-23
Fundamentals (TTM)
As of 2026-07-23
Market Cap
$171.33M
Beta
0.44
Shares Out
45.93M
P/E (TTM) · Derived
-65.3
P/S (TTM)
6.60
P/FCF (TTM) · Derived
956.41
Rev YoY
+22.1%
EPS YoY
-31.5%
Gross Margin
+60.1%
Op Margin
-10.3%
Net Debt
-$5.38M
Current Ratio
2.33
As of 2026-07-23 • Updated nightlySource: Internal modelMethodology